Skip to main content
Clinical Trials/NCT01951456
NCT01951456CompletedNot Applicable

Resistance Training as an Aid to Smoking Cessation Treatment

Teachers College, Columbia University1 site in 1 country180 target enrollmentStarted: November 1, 2013Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
180
Locations
1
Primary Endpoint
Smoking cessation

Study Overview

Brief Summary

The purpose of this study is to determine whether resistance training can aid smoking cessation.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Age 18 or older, smoke five or more cigarettes a day for at least the past 12 months

Exclusion Criteria

  • •Participating in any type of exercise for >60 minutes/week over the past 3 months, current smokeless tobacco use, participation in an ongoing effort to quit smoking, current or planned pregnancy, any serious medical condition that would make exercise unsafe

Arms & Interventions

Health and Wellness

Active Comparator

Participants in this group will be required to attend the exact same number of sessions as those in the Resistance Training group. Each session will last approximately 45-60 minutes. Sessions will include a practical component/demonstration, an informational video, and a handout on a pertinent healthy lifestyle topic for adults.

Intervention: Health and Wellness (Behavioral)

Resistance training

Experimental

Participants will attend two, 45-60-minute progressive, moderate intensity resistance training sessions per week for 12 weeks. The program will maintain a format of a 5-minute warm-up, 35-50 minutes of resistance training and a 5-minute cool-down with flexibility and abdominal exercises.

Intervention: Resistance training (Behavioral)

Outcomes

Primary Outcomes

Smoking cessation

Time Frame: Change from baseline to 3 months

Salivary cotinine-verified 7-day Point Prevalence Abstinence (7-day PPA) from nicotine (cigarette smoking).

Secondary Outcomes

  • Mood(3, 6, 12 months)
  • Body composition(3, 6, 12 months)
  • Cortisol(3, 6, 12 months)
  • Abstinence self-efficacy(3, 6, 12 months)
  • Glycosylated hemoglobin(3, 6, 12 months)
  • Body weight(3, 6, 12 months)
  • Blood pressure(3, 6, 12 months)
  • Smoking cessation(Change from baseline to 12 months)
  • Cigarette cravings(3, 6, 12 months)
  • Lung function(3, 6, 12 months)
  • Cholesterol profile(3, 6, 12 months)
  • Aerobic fitness(3, 6, 12 months)
  • Sleep(3, 6, 12 months)
  • Muscular strength(3, 6, 12 months)
  • Smoking cessation(Change from baseline to 6 months)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials